-
Track & Monitor
![]()
Innovation in technology: Electron beam lithography
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the technology industry’s Electron beam lithography innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and experience...
-
Product Insights
New![]()
Net Present Value Model: Beam Therapeutics Inc’s BEAM-201
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Beam Therapeutics Inc’s BEAM-101
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BEAM-101 in Beta Thalassaemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BEAM-101 in Beta Thalassaemia Drug Details: BEAM-101 is under development for the treatment sickle cell...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BEAM-101 in Sickle Cell Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BEAM-101 in Sickle Cell Disease Drug Details:BEAM-101 is under development for the treatment sickle cell disease...
-
Company Profile
![]()
Beam Suntory Inc – Company Profile
Beam Suntory Inc (Beam Suntory), a subsidiary of Suntory Holdings Ltd, is a premium spirits company. It is one of the leading premium spirit companies that offer an extensive range of bourbons, whiskies, tequilas, rums and vodkas, cognacs, cordials and gin in its portfolio. The company owns several popular brands including Jim Beam, Knob Creek, Cruzan, Hornitos, Glen Garioch, Hakushu, Hibiki, Jim Beam, El Tesoro, 100 ANOS and Teacher's. Beam Suntory runs its operations in the Americas, Europe, Asia Pacific,...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BEAM-201 in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BEAM-201 in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drug Details: BEAM-201 is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BEAM-201 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BEAM-201 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) Drug Details: BEAM-201 is...
-
Product Insights
New![]()
Net Present Value Model: Molecular Templates Inc’s MT-0169
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Company Profile
![]()
Beam Global – Company Profile
Beam global formerly known as Envision Solar International Inc (Envision Solar) is a provider of energy security systems. The company's products include renewably energized electric vehicle charging systems, media and branding systems, energy security systems, patented solar tracking systems, energy storage systems, electric vehicle charging stations, and digital advertising packages. It also provides engineered solar powered products, EV arc systems, and solar tree systems, among others. Beam offers services such as solar energy solutions, financing, installation, outdoor marketing, solar energy...
Add to Basket -
Thematic Analysis
New![]()
Synthetic Biology – Thematic Intelligence
Synthetic Biology Thematic Report Overview Synthetic biology is commonly abbreviated to synbio. It involves the manipulation of genetic material to enhance specific characteristics or, conversely, stifle them. The ability to perform this manipulation quickly, precisely, and at a low cost has the potential to impact numerous sectors. From developing environmentally friendly luxury materials to novel cancer therapeutics and even the use of DNA as a new form of data storage, the forthcoming field of synbio unlocks several new realms of...
-
Thematic Analysis
![]()
Directed Energy Weapons – Thematic Intelligence
Directed Energy Weapons Thematic Overview Directed Energy Weapons (DEWs) are now rapidly transitioning from the sphere of experimental technologies to the actual battlefield as they reach a sufficient level of maturity to warrant deployment. The potential benefits of DEWs in terms of cost-saving, logistics, and accuracy have long been extolled by technical specialists around the globe. In recent years, militaries such as China, Israel, Russia, the UK, and the US have finally been capable of fielding those technologies through integration...
-
Product Insights
![]()
Beam Ppty – Haltwhistle Residential Community – Northumberland
Equip yourself with the essential tools needed to make informed and profitable decisions with our Beam Ppty - Haltwhistle Residential Community - Northumberland report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Olaptesed Pegol in Metastatic Pancreatic Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Olaptesed pegol in Metastatic Pancreatic Cancer Drug Details:Olaptesed pegol (NOX-A12) is under development for the treatment...
-
Product Insights
![]()
Beam Suntory – Distillery Manufacture Plant Expansion – Kentucky
Equip yourself with the essential tools needed to make informed and profitable decisions with our Beam Suntory - Distillery Manufacture Plant Expansion - Kentucky report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
![]()
London Corp – Beam Park Residential Development – Greater London
Equip yourself with the essential tools needed to make informed and profitable decisions with our London Corp - Beam Park Residential Development - Greater London report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Hyaluronidase (Recombinant Human) + Pertuzumab + Trastuzumab) in Breast Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Hyaluronidase (Recombinant Human) + Pertuzumab + Trastuzumab) in Breast CancerDrug Details:Hyaluronidase (recombinant human), pertuzumab and trastuzumab...
-
Product Insights
![]()
Jim Beam Brands – Boston Whiskey Production Facility Expansion – Kentucky
Equip yourself with the essential tools needed to make informed and profitable decisions with our Jim Beam Brands - Boston Whiskey Production Facility Expansion - Kentucky report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
![]()
TMR Queensland – Beams Road Rail Level Crossing Overpass – Queensland
Equip yourself with the essential tools needed to make informed and profitable decisions with our TMR Queensland - Beams Road Rail Level Crossing Overpass - Queensland report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
![]()
BEAM – Research Triangle Park Research and Production Campus – North Carolina
Equip yourself with the essential tools needed to make informed and profitable decisions with our BEAM - Research Triangle Park Research and Production Campus - North Carolina report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.